The U.S. District Court for the Northern District of Illinois Dismisses Antitrust Case Challenging Patent Thicket (Humira)

e-Competitions (No. 96364, Sept. 2020)

7 Pages Posted: 10 Sep 2020 Last revised: 28 Nov 2020

Date Written: August 20, 2020

Abstract

Whether behavior relating to a patent thicket presents an antitrust issue is a nuanced question. But a recent ruling involving the biologic Humira shows how not to decide these issues. This short piece discusses the court’s opinion and highlights its errors analyzing sham behavior, patent settlements, and antitrust injury.

Keywords: antitrust, patent thicket, settlement, sham, injury, Humira

JEL Classification: I18, K21, L40, L41, L43, L65, O34, O38

Suggested Citation

Carrier, Michael A., The U.S. District Court for the Northern District of Illinois Dismisses Antitrust Case Challenging Patent Thicket (Humira) (August 20, 2020). e-Competitions (No. 96364, Sept. 2020), Available at SSRN: https://ssrn.com/abstract=3678198

Michael A. Carrier (Contact Author)

Rutgers Law School ( email )

217 North Fifth Street
Camden, NJ 08102-1203
United States
856-225-6380 (Phone)
856-225-6516 (Fax)

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
192
Abstract Views
1,740
Rank
284,996
PlumX Metrics